Cambridge, UK, 22 September 2017 | The British company developing the next generation surgical robot won first place at Cambridge Independent’s inaugural Entrepreneurial Science and Technology Awards
CMR Surgical, based in Cambridge UK, Europe’s Innovation Capital has beaten fierce competition to be awarded the best scale-up medtech company for developing surgical robot, Versius.
The award, which singles out the most innovative medtech company in the field, reflects CMR’s rapid growth since the company was set up three years ago. CMR now employs a team of more than 100 highly skilled engineers and designers, having more than doubled in size within a year.
The Cambridge Independent Entrepreneurial Science and Technology Awards ceremony commends a collection of brilliant start-up and scale-up companies.
Charles Cotton, serial entrepreneur and a judge at the awards ceremony, said, “It’s impossible to ignore the urgent need to revolutionise surgery and bring better techniques to patients around the globe. CMR’s surgical robot is truly innovative and has the potential to really impact the lives of millions of patients worldwide. CMR is definitely the one to watch.”
CMR will help to realise the potential of minimal access surgery aiming to be one of the largest surgical robotic companies internationally in five years, with a long-term ambition to have a robot in every major hospital.
Martin Frost, CEO of Cambridge Medical Robotics, said: “We’re thrilled to win best scale-up in the medtech category this year. Given the impressive level of innovation coming out of Cambridge, we are honoured to be awarded such a prestigious prize.”
Notes to Editors:
About CMR Surgical Limited
CMR Surgical is a private, British, company developing the next-generation universal robotic system, Versius®, for minimal access (or “keyhole”) surgery.
The vision behind CMR is to make minimal access surgery universally accessible and affordable, transforming the existing market for surgical robotics and addressing the six million people who still undergo open surgery each year.
Global annual revenues for robot-assisted minimal access surgery are presently approximately $4 billion and are anticipated to reach $20 billion by 2025.1
CMR Surgical, formed in 2014, has its headquarters in Cambridge, United Kingdom and is backed by an international shareholder base of specialist and generalist investors. The Company achieved the registration of its Quality Management System to ISO 13485:2003 by Underwriters Laboratories LLC® (‘UL’), and the status as a UL Registered Firm, in September 2015.
For further information, please visit: www.cmrsurgical.com
About the CMR surgical robotic system
Designed to meet the complex requirements of laparoscopic surgery, Versius’ compact size fits easily in the existing surgical workflow, while its ergonomic console design allows surgeons to work in a way that reduces physical and mental effort. Intended to be used across a range of surgical specialties, the versatility and portability of Versius – enabled by a unique and patented four-axis wrist joint – expands the potential for higher utilisation. This allows healthcare providers to offer the benefits of robotic-assisted procedures in a cost-effective way.
1 Industry Forecast, Accuray Research